tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OVID Stock Latest News

CWAN, HTBK, OVID, MCFT, WHWK Trending With Analysts
Weekend UpdatesCWAN, HTBK, OVID, MCFT, WHWK Trending With Analysts
2d ago
CWAN
HTBK
Ovid Therapeutics initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Ovid Therapeutics initiated with an Outperform at LifeSci Capital
7d ago
OVID
Ovid Therapeutics: Positive KCC2 Platform Progress and Underappreciated Pipeline Optionality Support Reiterated Buy Rating
PremiumRatings
Ovid Therapeutics: Positive KCC2 Platform Progress and Underappreciated Pipeline Optionality Support Reiterated Buy Rating
7d ago
OVID
Ovid Therapeutics: De-Risked KCC2 Platform and OV329 as Key Drivers of Long-Term Growth Support Buy Rating
PremiumRatings
Ovid Therapeutics: De-Risked KCC2 Platform and OV329 as Key Drivers of Long-Term Growth Support Buy Rating
10d ago
OVID
Ovid Therapeutics: Early KCC2 Proof-of-Mechanism and High-Potency OV4071 Pipeline Support Buy Rating and Attractive Long-Term Risk‑Reward
PremiumRatings
Ovid Therapeutics: Early KCC2 Proof-of-Mechanism and High-Potency OV4071 Pipeline Support Buy Rating and Attractive Long-Term Risk‑Reward
10d ago
OVID
Ovid Therapeutics Advances Oral KCC2 Activators After OV350 Data
PremiumCompany AnnouncementsOvid Therapeutics Advances Oral KCC2 Activators After OV350 Data
10d ago
8K
OVID
Ovid Therapeutics reports Phase 1 results for KCC2, OV350 IV
Premium
The Fly
Ovid Therapeutics reports Phase 1 results for KCC2, OV350 IV
10d ago
OVID
Ovid Therapeutics files to sell 125.06M shares of common stock for holders
Premium
The Fly
Ovid Therapeutics files to sell 125.06M shares of common stock for holders
13d ago
OVID
Ovid Therapeutics Stockholders Approve Key Proposals
PremiumCompany Announcements
Ovid Therapeutics Stockholders Approve Key Proposals
17d ago
8K
OVID
Ovid Therapeutics initiated with a Buy at Roth Capital
PremiumThe Fly
Ovid Therapeutics initiated with a Buy at Roth Capital
18d ago
OVID
Ovid Therapeutics appoints Kaufmann as Chief Medical Officer
PremiumThe Fly
Ovid Therapeutics appoints Kaufmann as Chief Medical Officer
27d ago
OVID
Ovid Therapeutics price target raised to $2 from $1.50 at H.C. Wainwright
PremiumThe Fly
Ovid Therapeutics price target raised to $2 from $1.50 at H.C. Wainwright
1M ago
OVID
Leerink bullish on Ovid Therapeutics, initiates with an Outperform
PremiumThe FlyLeerink bullish on Ovid Therapeutics, initiates with an Outperform
1M ago
OVID
Ovid Therapeutics initiated with an Outperform at Leerink
Premium
The Fly
Ovid Therapeutics initiated with an Outperform at Leerink
1M ago
OVID
Ovid Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
Premium
Ratings
Ovid Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
2M ago
OVID
Ovid Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Ovid Therapeutics Reports Q3 2025 Financial Results
2M ago
OVID
Ovid Therapeutics reports Q3 EPS (17c), consensus (15c)
PremiumThe Fly
Ovid Therapeutics reports Q3 EPS (17c), consensus (15c)
2M ago
OVID
Ovid Therapeutics appoints Alexander as CEO, Levin as Executive Chairman
PremiumThe Fly
Ovid Therapeutics appoints Alexander as CEO, Levin as Executive Chairman
2M ago
OVID
Ovid Therapeutics (OVID) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Ovid Therapeutics (OVID) Q3 Earnings Cheat Sheet
2M ago
OVID
Ovid Therapeutics price target raised to $5 from $3 at B. Riley
PremiumThe FlyOvid Therapeutics price target raised to $5 from $3 at B. Riley
3M ago
OVID
Ovid Therapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
Ovid Therapeutics initiated with an Outperform at Oppenheimer
3M ago
OVID
Ovid Therapeutics Secures $175.1M in Private Placement
Premium
Company Announcements
Ovid Therapeutics Secures $175.1M in Private Placement
3M ago
8K
OVID

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >